HUMAN TUMOURS IN CORTISONE-TREATED MICE
1956

Transplanting Human Tumors into Mice Treated with Cortisone

Sample size: 21 publication Evidence: moderate

Author Information

Author(s): Hans-Georg Iversen

Primary Institution: Finsen Institute, Surgical Department, and the Radium Centre, Copenhagen

Hypothesis

Can cortisone treatment improve the success of transplanting human tumors into mice?

Conclusion

Cortisone treatment significantly prolongs the survival of human tumors transplanted into mice, allowing for successful growth in some cases.

Supporting Evidence

  • Cortisone treatment allowed tumor tissue to survive for 10-45 days in treated animals.
  • Human ascites containing tumor cells led to the development of ascites tumors in cortisone-treated mice.
  • The study demonstrated that cortisone could suppress the immune response to allow tumor growth.

Takeaway

Researchers found that giving cortisone to mice helped human tumors survive better when transplanted into them.

Methodology

Mice were treated with cortisone before receiving human tumor transplants, and their survival and growth were monitored.

Limitations

The study primarily focused on specific tumor types and may not generalize to all human tumors.

Participant Demographics

Mice from a subline of the Bagg strain, with equal numbers of each sex used in experimental and control groups.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication